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ABSTRACT 
 
CORRELATION OF MICROBIAL CULTURE OF STENT AND 
SYMPTOMATOLOGY IN PATIENTS WITH LOWER URINARY TRRACT 
SYMPTOMS (LUTS) AFTER DJ STENTING 
 
AIM :  
To compare the microbial culture of DJ stents to that of symptomatology, in 
patients having lower urinary tract symptoms after DJ stenting. 
MATERIALS AND METHODS: 
Patients who were admitted in Kilpauk Medical College and Govt.  Royapettah 
Hospital   and undergone DJ stenting following which they developed 
significant lower urinary tract symptoms were included in the study. 45 patients 
were followed up prospectively and were observed and assessed for severity of 
stent related lower urinary tract symptoms using IPSS questionnaire.Vesical end 
of DJ stent was subjected to microbial culture and sensitivity. The result of 
microbial culture positivity of DJ stent was correlated to IPSS score, status of 
urine microbial culture, the relevance to timing of stent removal and other 
parameters 
RESULTS: 
The mean age of the study group was30.71 years. 28 were males and 17 were 
females.16 patients had stent on the right side and 25 had on the left side. 4 
patients had bilateral stenting. The mean IPSS score was 20.25. Dysuria was 
predominant in 66.4%, frequency in 22.7% and urgency in 7.2 %. Female 
patients had more incidences of severe IPSS. Moderate IPSS (8-19) noted 
predominantly in 26-30 years.in the group 31-35 years it was predominantly 
severe (IPSS 20-35).62.2% gave Quality of Life score of 4. 15.5% had a score 
of 5. 8 patients gave the score as 3 and 2 patients gave a score 6. Adjusted to 
bilaterality, DJ stent culture was most commonly E.coli followed by 
kelbsiella,pseudomonas,enterococcus. The same pattern of hierarchy noted in 
urine culture. When analysed with SPSS v2 software, age and sex were not 
significant determinant of positive stent culture, nor they predicted severe IPSS 
score. IPSS score correlated positively with DJ stent culture. Statistical 
significance was seen when IPSS was tested against combine positivity of DJ 
and urine culture (P value 0.001). Urine culture in predicting positive stent 
culture had 48.3% accuracy. Stent removal was early in patients with severe 
IPSS and was statistically significant when correlated to combined microbial 
positive culture (P value 0.003) 
CONCLUSION: 
Stent related symptoms are a significant problem and the prevalence is 
common. Age and sex of the patient does not predict severity of stent related 
symptoms nor they are linked to positive stent culture. The quality of life based 
on IPSS questionnaire shows that majority of the patients are unhappy with the 
bothersome nature of stent related symptoms. Early stent removal was 
statistically associated with positive microbial culture (DJ stent, urine and 
combined) and severity of IPSS. Urine culture is not a strongly predictive 
variable for positive DJ stent culture.  
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INTRODUCTION 
By deﬁnition, the double-J or pigtail stent is a tube placed within the ureteral 
lumen in a retrograde or antegrade fashion in order to maintain its patency. The 
double-J ureteral stent had been widely applied during the endourologic surgery to 
relieve or prevent ureteral obstruction. Stent-related morbidities, such as lower 
urinary tract symptoms (LUTS), stent-related body pain and hematuria, are 
bothersome and might have a negative impact on quality of life (QoL) and sexual 
performance for both genders. Stent discomfort can vary from one patient to 
another in an idiosyncratic manner, but is believed to affect over 80% of patients. 
The prevalence hence is significant and geographic4variance might exist. This 
makes this issue an important health problem and indirectly serves as a scale for 
quality of healthcare delivery to the public. The pathophysiology of stent-related 
symptoms remains unclear. However, the pain and LUTS caused by stent 
placement has been attributed lower ureter and bladder spasm due to local irritation 
of the stent. Studies utilizing pharmaco therapeutic agents like Tamsulosin and 
other antimuscarinics and blockers were shown to improve symptoms but the 
benefit is obtained by preventing unwarranted bladder5contractility or other 
unknown mechanism (in case ofblockers) . In all these studies the primary 
problem is not addressed and remains unknown. Patients who fail to respond to 
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such pharmacotherapy are left with limited options or else removal of the stent 
(irrespective of the consequence). Also, attempt to modify the design of bladder 
end of the stent was studied (James E. Lingeman et. al). The results showed no 
significant difference among the groups. A complete understanding of the 
pathogenesis of stent-related symptoms is limited by the lack of systematic 
analysis of the same. The role of micro-organisms (pathogenic/opportunistic) in 
this scenario is less investigated and reported. 
An important problem here is to develop a validated22, reliable and simple tool for 
symptom analysis. Ureteral Stent Symptoms Questionnaire (USSQ) is a very 
useful standard tool for such analysis. USSQconsists of 38 items and 6 
subdivisions: overall general health,pain, work performance, voiding symptoms, 
sexual matters, and additional problems. USSQ is a lengthy and complicated 
instrument. Its very complexity poses problem when it is applied to large 
population. Furthermore it has been shown that such complex questionnaire 
requires certain minimum comprehensive capacity on the patient part which is of 
definite concern in reference to our society, as well as in other developing nations. 
IPSS scores over USSQ in its relative simplicity. The real need is development and 
validation of an ideal research tool that should first address the needs of our 
society, which is ironically lacking till date18. 
 This study in part tries to address some of the questions raised above. 
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AIM OF THE STUDY 
To compare the microbial culture of DJ stents to that of symptomatology, in 
patients having lower urinary tract symptoms after DJ stenting. 
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REVIEW OF LITERATURE 
HISTORY OF EVOLUTION OF URETERAL STENT: 
Ureteral stents are used to ensure patency of ureter in situations where it 
could be compromised. Their primary purpose is to ensure urine drainage from 
renal pelvis to urinary bladder. Mostly they are used for temporary relief of 
obstruction of ureter. In 1800 A.D Dr. Gustav Simon describes inserting a tube into 
a ureter during open bladder surgery. He is credited with being the first person to 
“stent” a ureter. In 1900A.D Dr. Joaquin Albarranocreated the first ureteral stent. 
Stents at that time were typically made of fabric covered in lacquer varnish.  In 
1967 Dr. Paul Zimskind reports insertion a straight silicone tube into a ureter to 
relieve obstruction. In their report, they referred to the device as a “ureteral splint”. 
This is the first use of a stent that is placed endoscopically (using a camera) instead 
of through an open incision. It represents the beginning of the modern era of 
ureteral stents. However, because the stent is straight, these stents are prone to 
accidentally slip out. Dr. James Montie coined the term “stent” to refer to 
indwelling tubes placed in the urinary tract in the year 1973. The common problem 
with the early stents was their tendency to migrate.In the year 1974 McCullough 
described the use of a “shepherds crook” stent to prevent the stent from slipping 
down and out of the kidney. The shepherds crook design was borrowed from 
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existing stents meant for insertion into blood vessels. While the stent no longer 
migrated downwards due to the upper curl, it was still prone to slipping upwards 
into the kidney. The important problem of stent migration was solved in 1978 
when double-J (DJ) stents were described by Finney. The tips of these stents are J-
shaped on either side to prevent upward or downward migration; hence they got 
their name “Double J”. Further advancements14 made in 1989, when amagnetic 
tipped “Magnetip” double J ureteral stent is introduced by ACMI. This can be 
removed using a magnet instead of by cystoscopy (insertion of a camera). 
However, it is no longer on the market, probably because removal using a 
“Magnetriever” was not always reliable. In one study, only 86% of Magnetip stents 
were removed successfully, while the others required traditional cystoscopy for 
removal. Despite enormousadvancement in stent biomaterials and design, DJ stents 
are not free of complications and problems and the search for an ideal DJ stent may 
remain utopian. DJ stents are usually made from silicon or polyurethane. They are 
available in different sizes and length. Commonly used stents are of 24-30 cm 
length. They are inserted commonly with help of cystoscopy or ureteroscopy 
during an endourological procedure. Removal of the stents may be simple pulling 
of threads(in case of stents with threads attached) or may require cystoscopy for 
removal. As  mentioned previously, stents with magnetic property could be 
removed using magnets. Ideal stent characteristics are easy insertion, completely 
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internal placement, resistance to migration, easy removing, radio-opacity, 
biologicalinertion, and chemical stability, resistance to encrustations, non-
refluxing, excellent flow characteristics and reasonable price. Till date an ideal 
stent is yet to be developed. The most noticed problem is growth on the surface of 
stent. This could be 1) Tissue ingrowth 2) Growth of Micro organism 
3)Combination of both. Modern day stent32 would focus on these problems and 
would be designed to solve these problems. Recent interest in metallic stents has 
been sought with expectation. There are four general types of Metallic stents for 
ureteral use: 1) Self-expanding 2) Balloon-expandable 3) Covered 4) 
Thermoexpandable - stents. The most commonly used metallic stents in the ureter 
are the self-expanding stents. However urologists’ interest has recently reoriented 
to covered stents, in an effort to minimise tissue ingrowth and resist microbial 
colonisation. Further developments in this line might see more refinement in stent 
technology. But till date no stent is ideal. This study focuses on certain issues 
which would be unaltered despite advancement in stent technology. This is based 
on the fact that any stent is a foreign body and the body response will be complex. 
Hence an analysis of these aspects which have little supportive data will enlighten 
more towards better patient outcome 
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PREVALENCE OF STENT RELATED COMPLICATION: 
 Stent related complications are more common. Hence numerous studies are 
available to document this phenomenon of stent related 18,22,30complications by 
various authors. Let us consider the various published evidence on this topic as 
below. 
Author  Frequency Dysuria   Urgency Suprapubic 
pain  
Flank 
pain 
Haematuria 
Borboroglu 
et al 
30/100 - 30/100 35/100 40/100 - 
Byrne 
et al5 
3.6/5 1.4/5 3.6/5 3.1/5 3.4/5 1.1/5 
Chen et al6 
 
25 Pts of 30 
pts 
 25 Pts of 
30 pts 
2.3/10 2.3/10 - 
Cheung 
et al7 
 
-no data- 23 Pts of 
29 pts 
-no data- 2.7/10 19 Pts of 
29 pts 
16 Pts of 29 
pts 
Denstedt 
et al9 
 
5.5/10 5.1/10 5.5/10 3.5/10 4.1/10 - 
Damiano 
et al8 
 
30 Pts of 50 
pts 
28 Pts of 
52 pts 
30 Pts of 
50 pts 
- 2.6/10 10 Pts of 52 
pts 
Srivastava 
et al12 
16 pts of 26 
pts 
18 Pts of 
26 pts 
16 pts of 
26 pts 
2.23/10 12 Pts of 
26 pts 
- 
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Table above shows the results of multi-institutional meta-analysis. The study by 
various authors shows that majority of the patients report of irritative LUTS post 
stenting. Frequency and urgency are most commonly reported patient discomfort. 
Dysuria comes next in the order. Some patients report of suprapubic pain. 
Interestingly haematuria is not that common in all these studies. The prevalence of 
these symptoms (irrespective of the frequency of occurrence) is about a mean 50% 
when considered individually. The cumulated frequency is well over 80 - 90%. 
This result is consistent among other authors from all over the world in various 
reports. The single least occurrence reported4 was 14% in 106 patients after DJ 
stenting by John et,al. Infact all these studies have not reported other morbidity 
related with stenting like pyrexia, urosepsis, work performance and psychological 
problems. It is however very clear from these studies that the spectrum of stent 
related LUTS is very varied in presentation. 
The significance of stent related patient discomfort is less realized in routine 
urological practice. An analysis of stent related LUTS and its bothersome nature to 
the patient should be given due attention both in the outpatient and inpatient 
setting. An understanding of the problem and pathogenesis might guide to solve 
the problem better in critical situations. This is especially true in patients with stent 
related LUTS in situations like pregnancy and solitary kidney.  
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STENT RELATED SYMPTOMS AND QUALITY OF LIFE: 
Innumerable symptoms occur25 after DJ stenting. The symptoms vary from 
flank pain, lower abdominal pain, debris in urine, increased frequency of 
micturition, nocturia, urgency,incontinence, dysuria. Also there are other indirect 
and non-urological projections of these symptoms which include work 
performance, sexual matters, psychological distress and sense of general ill-health. 
In patient’s words they describe themselves as “helpless”, when they have stent 
related symptoms. Most of them have to restrict themselves from work due to pain. 
A number of studies have concluded that DJ stent related symptoms vary from 
40% - 82%. RachidYakoubi et.al in their study found stent related bothersome 
symptoms in 80% of patients. The prevalence of the problem does not seem to very 
much with geographical location. Only minimal evidence is available on this 
regard. Nazaralimemon et.al of Pakistan found overall stent related complications 
in79.2%. In their study much data is available only on long term complications. 
They concluded that stent related complications are mostly due to mechanical 
properties of stent. But in contrast they recommended routine culture and 
sensitivity of urine in patients with stent related complication, as a concluding 
reark in their study. Thus it emphasizes again on the role of microbial culture in 
stent related symptoms, even though the problem may appear to be mechanical. 
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Chatterjee S et.al, analysed culture of urinary catheters and stent in their study. The 
study setting is in a tertiary hospital in India. They cultured 150 catheters and 31 
DJ stents. Among them 130 catheters had microbial growth noted as significant. In 
their study all 31 DJ stents (100%) are positive for significant growth of bacteria. 
The study is very relevant because 1) Information is very well comparable to the 
setting of this study (a tertiary hospital in India). 2) Prevalence of positive stent 
culture is high (here it is 100%), and it is higher than that of catheters. This gives 
the clue that growth of microorganism on stent is an independent and a definite 
phenomenon which is often underestimated. The short coming of this study is that 
no correlation has been made with the clinical presentation of the patient. However 
the concluding remarks by the author are very valid. 
1) Microbial growth on any urinary device is the rule rather than the 
exception, and  
2) Such colonizations are mostly monobacterial with multiresistant 
organisms  
The work by Joshi et.al is remarkable in the view of information on this problem in 
an entirely different perspective. H.B. Joshiet. Al24 studied these bothersome 
parameters using validated questionnaire, with emphasis on Quality of Life(QOL). 
They concluded that Indwelling ureteral stents have a significant impact on Quality 
of life. In another study by the same author quantified the previous statement. The 
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author noticed reduced Health related quality of Life (HRQoL) in 80% of patients 
having DJ stents.  
It is worth noticing that the psychological problem of patients with DJ stent 
is least evaluated and addressed in urology clinic. The classic study by Rocco 
Damianoet. al, demonstrates this aspect. The study was intended to study the Size 
of Ureteral Stent and its Impact in Urinary Symptoms and Quality of Life. In this 
study the author found no difference of symptoms and that of the size. But 
shockinglya high percentage of patients reported depression and anxiety associated 
with the stent. Hence the conclusions are 1) Stent size do not correlate with 
symptoms (hence the pathogenesis of stent related symptoms not necessarily 
confine to the physical characteristics of the stent. 2) Supports the previous 
statement that psychological impact25 is more than actually thought about (the 
exact prevalence remains unknown). Perhaps the entire spectrum of 
symptomatology itself might be due to varied individual levels of tolerance and 
mental well being. 
ShenPengfei et.al in their extensive meta-analysis showed that stent related 
symptoms affect significant percent of the population. In their study the morbidity 
was so significant it made them to issue a word of caution against unnecessary 
stenting. 
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INDICATORS THAT STENT RELATED SYMPTOMS ARE 
INDEPENDENT VARIABLES:  
 Stent insertion results in stent related symptoms. Though the insertion of 
stent seems to be causative for the outcome, analysis of available literature 
indicates otherwise. Stent related symptoms are independent of the stent itself. This 
also means, the symptoms are independent16 of the design, material it is made up 
of, surface property and to some extent indication for stenting. The following 
literature review highlights these points 
 
1)Modification of stent : 
It has been hypothesized that the distal curl of the stent is the mian cause of 
stent related symptoms. In order to decrease ureteral stent-related bladder 
irritability, the ‘tail stent’is designed toincorporate a tapered straight distal tail that 
resides in the bladder. Dual durometer stents incorporate a transition from a firm 
biomaterial at the renal end to a soft biomaterial or a fine loop at the bladder end, 
in an attempt to facilitate stent placement, reduce migration and minimize patient 
discomfort due to bladder irritation. In the most famous comparative study by 
Lingeman JE et al, the author found that there is no statistical difference in 
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symptom improvement noted. This ndirectly points out that stent related symptoms 
are not entirely due to stent design. 
2) Adding pharmacological agents: 
Then came the novel concept of Drug eluting Stents(DES). Antibiotic eluting 
stents were tried initially. Following the idea several other substances have already 
been used in DESs in an attempt to diminish stent-related adverse effects. 
Promising results have been demonstrated in the case of ureteral stents loaded with 
Triclosan and Ketorolac. Triclosan is29 a broad-spectrum antimicrobial agent 
incorporated on ureteral stents to prevent stent infection. When Triclosan-eluting 
stents were indwelled for 3 months in eight patients a decreased antibiotic usage 
and significantly fewer symptomatic infections were noted. Nevertheless, a clinical 
benefit in terms of urine and stent cultures or overall subject symptoms was not 
revealed. Obviously these studies raise the following suspicion 
1. There is no control over the release of drug and no way to ensure its working 
2. The problem of drug resistence (antibiotic resistence) is not addressed 
3. Most such stents have been tested only in vitro and results may not be 
comparable in vivo 
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3) Pharmaco-therapeutic manipulation: 
Various pharmaco therapeutic agents were tried to circumvent the 
symptoms. They were the anti-cholinergics and α-blockers. The drugs tried were 
tolterodine,tamsulosin,alfuzosin etc. The trouble is that the primary problem is not 
addressed13. This is important especially in the patients who fail to respond to such 
agents. These patients were left with limited options which include removal the 
stent (irrespective of the consequence).  
The following table summarizes these studies and their results. 
 
Parameter studied Author Result / Conclusion of the study 
Modification of the 
vesical end of stents 
 
[Stent with loops of 
loose plastic strings at 
the distal end – 
Percuflex “tail” stent] 
Lingeman JE et al No statistical difference in 
symptom improvement  noted 
Modification of the 
vesical end of stents 
 
[stent made with softer 
plastic on the lower 
end ] 
 
Davenport et al Stents failed to reduce patient 
discomfort 
Use of Drug (triclosan)- Cadieux PAet al Triclosan-eluting stent alone is not 
sufficient to reduce device-
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eluting ureteral stents 
 
associated infections and 
symptoms. 
Use of α-blockers 
(Tamsulosin) 
 Rocco Damianoet al Primary problem not addressed, 
non-responders have limited 
option 
Use of 
tolterodine&alfuzosin 
SeungChol Park et al Primary problem not addressed, 
non-responders have limited 
option 
 
 All these studies indicate that a significant percentage of patients persist to 
have bothersome symptoms or suffer stent related complications in each of the 
group above. This again indicates that the problem is not related to mechanical 
properties of stent nor the problem could be circumvented by pharmacological 
manipulation. 
TOOLS FOR SYMPTOM ASSESSMENT: 
Lower urinary tract symptoms LUTS is a global term that includes storage 
symptoms, voiding symptoms as well as post micturition symptoms. The term 
LUTS16 has clear definition and meaning. It comprises of group of defined 
symptoms which are non-sex specific and non-organ specific. IPSS is an important 
tool to assess LUTS 
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IPSS 
IPSS was designed to be self-administered by the patient with speed and ease in 
mind. Hence it can be used in both urology clinics as well the clinics of primary 
care clinicians (General practitioners). In addition IPSS could be repeated multiple 
times with reproducible result. IPSS consists of seven questions and can be divided 
in to  
1) Voiding symptoms  
a. Incomplete emptying  
b. Intermittency 
c. Weak stream 
d. Straining  
2) Storage symptoms 
a. Frequency  
b. Urgency  
c. Nocturia 
 
The characteristic additional feature of IPSS is that though it comprises of 
parameters related to these two groups of symptoms, it is not cause specific. It 
means that by applying the above questionnaire one cannot diagnose the cause.  
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Though it might appear as a short coming, it is in fact an advantage in other 
perspective. The IPSS score could be applied to measure the bothersome level of 
these symptoms in any pathologic condition that produces these symptoms. This 
could be as varied as from Urinary tract infection to BPH. As mentioned 
previously its lack of specificity to organ or sex makes still more versatile. The 
striking advantage is its ease in use. 
 
The IPSS was originally based on the American Urological Association 
seven item symptom score (AUA-7). The 'Quality of Life' question was added by 
the World Health Organization when it was adopted by the International 
Consensus Committee as an international questionnaire for evaluating prostatic 
symptoms. Although the single 'quality of life' question may not capture the full 
impact of prostate symptoms, it can be used as a starting point for a doctor-patient 
discussion on management. 
IPSS is well validated for assessment of LUTS after DJ stenting. This concept 
was proposed by H.B. Joshi et al in 2002 in their article. They prospectively 
studied the prevalence and bother of various urinary tract symptoms caused by 
indwelling ureteral stents using validated questionnaires, which was IPSS. The 
study consisted of 60 patients with unilateral ureteral stents. Of these, 30 patients 
were asked to complete the International Prostate Symptoms Score questionnaire, 
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with additional questions on dysuria, hematuria, and loin pain. The remaining 30 
patients were asked to complete the International Continence Society 
questionnaire. The questionnaires were completed with a stent in situ and 6 weeks 
after its removal. Forty-eight patients (36 men and 12 women, mean age 52.8 
years) completed the study. A large proportion (80%) of patients reported one or 
more urinary symptoms. Analysis of the IPSS data revealed impaired global 
quality of life owing to these urinary symptoms.  The results of the International 
Continence Society study to a lesser extent were helpful. The author concluded that 
Patients with indwelling ureteral stents have a wide range of urinary symptoms that 
affect their quality of life. Validated questionnaire are useful in better 
understanding the urinary symptoms associated with stents and in providing patient 
counseling. The author also remarked that none of the existing questionnaires 
covered the entire range of symptoms,( it in turn made the same author to propose 
another questionnaire which we would discuss subsequently). It is because in their 
study they found a significant incidence of haematuria which is not present in the 
questionnaire, they made such final remark. But we could see in the multi-
institutional study (discussed above) that haematuria is relatively less frequent 
among various authors. In summary by this study we could ascertain on the 
following facts. 
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1) Patients with indwelling DJ stents have wide range of symptoms 
2) The prevalence of these symptoms affect significantly the quality of life of 
these patients 
3) IPSS is well validated and could be used to analyse and document stent 
related bothersome symptoms. 
4) IPSS is helpful in providing counseling for patients 
 
Ureteral stent symptom questionnaire (USSQ) 
It is a psychometrically23 valid measure to evaluate symptoms and impact on 
quality of life of ureteral stents. It was used to evaluate stent related symptoms by 
Joshi et al. in their study published in 2002. USSQ was designed to cover most 
aspects of the problem and was claimed to be superior to IPSS in assessment of 
stent related symptoms. The final draft of USSQ addressed various domains of 
health affected by stents covering urinary symptoms, pain, general health, work 
performance, sexual matters and additional problems. It had 6 sections and 38 
items. A total of 309 patients were asked to participate during different phases of 
the study. In phase 1 a structured literature search, 9 patient interviews and studies 
of 90 patients using existing instruments formed the foundation for the initial draft 
of our new questionnaire. In phase 2 the USSQ was pilot tested, reviewed by 
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experts and field tested in 40 patients to produce a final 38-item draft. In phase 3 
formal validation studies were performed in 55 patients to assess validity, 
reliability and sensitivity to change. Discriminant validation was performed by 
administering the questionnaire to 3 groups of patients without stents. The 
validation studies showed the questionnaire to be internally consistent (Cronbach’s 
α >0.7) with good test-retest reliability (Pearson’s coefficient >0.84). The 
questionnaire demonstrated good construct validity and sensitivity to change 
shown by significant changes in the score with and after removal of stents.  
Again the author in their concluding remark stated that Indwelling ureteral stents 
have a significant impact on health related quality of life. 
Advantage of IPPS over USSQ 
Now, we could observe that USSQ is very elaborate. The total number of 
items was 38. This is more than fourfold as that of IPSS. More over information on 
the test- retest reliability and application across wide section of population is yet to 
become available. As far as our society is concerned the population seeking 
treatment at government hospital has certain characteristics of its own. It is obvious 
(though not claimed for authenticity) that majority of the patients are economically 
burdened and have little education. They comprise the study group of this analysis. 
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It is impractical to expect these people to comprehend and complete the tedious 
USSQ. When in need for simplicity, IPSS is obviously superior.  
MICROBIAL CULTURE AND BIO FILMS 
Biofilms : 
A bioﬁlm is an accumulation of microorganisms and their extracellular 
products forming a structured community on a surface. 
It is known that improvement of stent related morbidity is possible only by 
proper understanding of the various aspects of growth of pathogens on surface of 
biomaterials. Dirk Lange et al. in their study urged the need to understand this 
basic phenomenon first before proposing altered stent design including the latest 
Drug Eluting stents. In their view it is not possible or it is waste of time and 
resource to propose newer concepts for modern stents, if the pathogenic process is 
not completely understood. It in turn begins with the concept of microbial culture 
on these biomaterials which is the primary hypothesis for the study.   
It is known that bacterial biofilms can colonise the surfaces of both tissues 
and implanted medical devices. The process of biofilm formation and the impact 
on the development and clinical course of infectious diseases, however, are still 
poorly understood. Effective preventive and therapeutic strategies still need to be 
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developed for device-associated infections. It is evident that with the steadily 
increasing number of biomaterial devices used in urology for urinary drainage like 
DJ stenting increases the incidence of device associated problems most in fact 
might be due to bacterial growth and biofilm formation. 
 
The formation of biofilm generally consists of several main steps: the first 
step is the deposition of the microorganisms, next follows their attachment by 
microbial adhesion and anchorage to the surface by exopolymer production. After 
this process their growth, multiplication and dissemination can be observed. The 
initial event in this process is bacterial adhesion and the deposition of a host 
urinary component on the surface of the biomaterial leading to the formation of a 
conditioning film. The conditioning film does not cover the stent surface, but 
rather forms a “mesh-like” covering. The biofilm is usually built up of three layers. 
The linking or conditioning film is attached to the surface of a tissue or 
biomaterial, the biofilm base consisting of microorganisms and the surface film 
acts as an outer layer where micro-organisms can be released free-floating and 
spread to the surrounding compartments. The clinical importance is the failure of 
antimicrobials to penetrate these biofilms. 
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The prevalence of microbial growth and biofilm formation over DJ stents 
were not extensively studied. Information available in this regard is non-
systematic, underpowered and not representative of general population. 
S.Chatterji et.al studied the microbial culture of urinary catheters and indwelling 
ureteral stents in a random population within a hospital. 150 uro catheters and 31 
ureteric stents were cultured. They made the following conclusions. 
1)  89.33% of cases were positive for presence of biofilms. 
2) Mono-bacterial Biofilms were exclusively seen on DJ stents 
3) Bacteriuria demonstrated in the same patients though insignificant pointed 
towards biofilm. 
The last conclusion means that demonstration of bacteriuria alone is not 
sufficient to confirm stent colonization and biofilm formation over indwelling DJ 
stent. In fact that bacteriuria is not mandatory in their study, indirectly points 
towards its poor reliability. The author made the final remark that bacterial 
colonization and biofilm formation was an inevitable phenomenon in case of DJ 
stenting. 
Another study by Cormio Let,alanalysed the biofilm formation on various 
stent types in porcine model.  23 double-J stents of 8 different types were tested. 
They used scanning electron microscopy in their analysis. They found that there 
was no statistically significant difference in bacterial adherence to the various stent 
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materials.the final conclusion was microbial adhesion appeared to depend on the 
virulence of the bacteria rather than the properties of the biomaterials. This study 
has its limitation primarily because it was tested in porcine models. Still the 
conclusions were very illustrative of the problem of bacterial adhesion, virulence 
and biofilm formation on biomaterials. 
Reid Get, al in their illustrative study sealed the remaining confusion with 
more certainity. Thirty ureteral stents were studied for microbial growth and 
biofilm formation. This study could be lauded for the fact that the author included 
urinary culture of these patients. They found pathogenic micro organism in 90% of 
the cultures. A definite biofilm was demonstrated in 55% of cases. The author also 
documented prescription and usage of antibiotic in all the patients (100%). This is 
a remarkable observation. The author made the following useful observations 1) 
Bacterial biofilms do occur on ureteral stents and urinary culture may not detect 
their presence  2)  Unlike biofilm formation on many other prosthetic implants, 
colonization with Gram positive organisms on ureteral stents does not necessarily 
coincide with the development symptomatic infection. 
So we could see from this study that microbial growth on DJ stent is unique 
and urinary culture may not detect it. The unreliability of urinary culture is 
demonstrated in other studies too. Though some studies show positive correlation 
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to urinary culture and stent culture (Joshi Ret,al in 2011), the inconsistency of 
these findings go well with the initial conclusion that urinary culture is not of 
substantial reliability. In addition we could also see that antibiotic prophylaxis has 
negligible effect on this phenomenon. The only limitation in this study is “How 
many patients were clinically symptomatic?”.Which we tend to address in this 
study of correlation of microbial culture to that of stent related LUTS. 
Another study by GernotBonkat et al, also highlights the unreliability of urine 
culture done in conventional manner in predicting stent infection. The study was 
conducted comparing conventional urine culture to stent culture where the stent eas 
subjected to a process called sonication. The author definitely concludes that 
conventional culture may not detect infection on biomaterials like stents or 
catheter. The short comings of the study are when the culture is positive. In 
patients where culture is positive only after processing by sonication, the 
technology currently available is not standardized. In fact the process of sonication 
might even kill pathogens. But still the yield of microorganism by this process 
indicates a sterile urine doesnot exclude the presence of pathogens. Hence direct 
culture of the biomaterial (here it is DJ stent) is more reliable than conventional 
urine culture. 
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MATERIALS AND METHODS 
1. Study group   :   Patients who were admitted in Kilpauk Medical College and 
Govt.  Royapettah Hospital   and undergone DJ stenting following which they 
developed significant lower urinary tract symptoms were included in the study. 
2. Study design:      Prospective clinical study 
3. Materials: 
          Patient who had underwent DJ stenting with postoperative lower urinary 
tract symptoms were evaluated with a validated symptom specific questionnaire 
(International Prostate Symptom Score (I-PSS)). Patients with moderate to severe 
symptom score (8 and above) are studied.  Stent was subjected to microbial culture 
at removal. Results analyzed 
4. Study period – 1 year 
Inclusion Criteria: 
1. Patients who underwent DJ stenting (unilateral or bilateral) after 
intracorporeal lithotripsy for ureteric calculi.  
2. Patients undergoing ureteric stenting for the first time 
3. IPSS score 8 or above after DJ stenting 
4. Age between 20 to 40 years 
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Exclusion criteria : 
1. Histroy of severe lower urinary tract symptoms prior to DJ stenting 
2. Gross haematuria 
3. Associated bladder outlet obstruction 
4. History of tuberculosis/Diabetes mellitus/medications for chronic ailment 
5. Urine microbial culture positive at the time of DJ stenting 
6. Cystoscopy revealing Urinary bladder abnormality   
7. Residual stone in post operativeXray KUBU 
8. Lower coil of DJ stent crossing the midline 
9. Suspected stent migration 
10. Benign Prostatic Enlargement 
 
The study was approved by the institutional ethical committee. 
In our study the complete clinical information is documented which includes 
age, sex, place of living, present and past clinical history, personal habits etc. 
Presence of co-morbid illness and use of any medications were sought for and 
recorded. The reason for DJ stenting and the operative records were obtained. 
Patients were individually assessed for their presenting symptoms. IPSS 
questionnaire was used and patient was offered help only if there was any 
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difficulty in comprehension of the question. The primal focus was on ensuring 
patient understanding of the question.  No part of the question was modified. The 
results recorded. Patient underwent routine urological and basic biochemical 
investigations. A urine culture and sensitivity was done. A plain xray KUBU and 
USG examination were done in all these patients to look for any significant 
residual calculi. All these patients were subjected to stent removal observing 
maximum sterile precautions. The procedure was noted and any difficulty in 
removal of stent was recorded. The stent was received in a sterile culture tube and 
the distal end (vesical end) was cut with sterile scissors and sent for culture. The 
stent was processed in the microbiology department. It was initially cultured in 
Brain Heart Infusion broth (BHI) as soon as it is received in the department. Then 
isolates are cultured in McConkeyagar and Blood agar. Sensitivity for antibiotics 
was done subsequently. 
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OBSERVATION AND RESULTS 
In our study the mean age of the patients is 30.711 years. The age limit of the study 
population is between 20 -40 years. When correlated to age groups, the dominant 
group was between 26-30 years. 28 were male patients and 17 were female 
patients. 16 had stent on right side, 25 had stent on left side and4 had bilateral 
stents. 
Sample size 45 
Mean age 30.711 
Male  28 
Female 17 
Right side stent 16 
Left side stent 25 
Bilateral stents 4 
IPSS( mean) 20.25 
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STATISTICAL ANALYSIS 
Data were analyzed using the statistical analysis package SPSS version 20 for 
Windows and Medcal software. Three analyses were undertaken: 1)univariate 
analyses of the association of each variable with Stent culture 2) multivariable 
logistic regression to predict outcome of DJ stent related symptoms.3) ) 
multivariable logistic regression to predict outcome of DJ stent related symptoms 
and microbial culture of DJ stent (with or without culture of urine).  In the 
univariate analysis, Chi-square test and Fisher’s Exact Test was used for 
categorical variables and Student’s t-test or Mann-Whitney test was used for 
continuous variables. All testing was two-sided. Univariate relative risk ratios and 
multivariable analyses were done by assigning the continuous variables into 
discrete variables, based on their being above or below a set value. The 
Multivariable logistic analysis was done in a stepwise manner. One variable was 
entered at a time into the classification equation. The variables were tested 
individually one at a time and the results looked for. If significant it is tested in 
combination with additional variable and the statistically appropriate test done. 
Finally association between multiple variable was assessed.  
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Study group characteristics 
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IPSS: 
The mean IPSS was 20.25. The most common bothersome symptom (using IPSS) 
was dysuria(66.4%) followed by frequency(22.7%) and urgency (7.2%). 31 
(68%)patients had IPSS corresponding to ‘severe’ category(IPSS 20-35). 14 (32%) 
patients had IPSS corresponding to ‘moderate’ category(IPSS 8-19). 
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The symptom  wassubclassified and plotted for sex distribution. When analysed for 
correlation with sex severe females reported more of severe IPSS 70%.  
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IPSS was also correlated to the age group. The moderate symptoms (IPSS 8-
19) predominated in the age group 26-30 years. IPSS severe symptoms (20-35) 
existed in the age group 31-35 years 
 
 
IPSS severity(mean)correlated to age groups 
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IPSS Quality of Life: 
 All patients responded with the minimum score of 3(mixed feel regarding 
spending the rest of life with existing symptoms).28 patients (62.22%) had given a 
score of ‘4’ corresponding to ‘mostly dissatisfied’. 7 patients (15.55%) had 
reported IPSS QoL 5 corresponding to ‘Unhappy’. 8 patients (17.77%) reported 
IPSS QoL 6 corresponding to ‘terrible’, if they were to continue with existing 
symptoms. 
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Microbial culture: 
Microbial culture of urine was done as a part of routine urological workup. 
Upon removal of DJ stent it was cultured as described previously. 46specimens 
had growth of microorganism positive on the DJ stent (93.87%).When corrected 
for bilaterality the percentage was 93.33%. 20patients had positive urine culture 
(44.44%). All four patients with bilateral stents had the same organism grown in 
culture. The most common organism grown was E.coli in both DJ stent (48.8%) 
and urine culture (28.8%). The second most common organism was Klebsiella, 
followed by pseudomonas. Other organisms were Enterococcus, Proteus, 
Acinetobactor and Staph. aureus. The positive cultures were predominantly 
unimicrobial.   
Organism  DJ stent culture 
(Adjusted to bilaterality) 
Urine culture 
E. coli 22 13 
Klebsiella 7 3 
Acinetobactor 1  
Proteus 2 1 
Pseudomonas  5 2 
Enterococcus 4 1 
Staph. aureus 1  
No growth  3 25 
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Age Vs IPSS: 
The age group were analysed for association with severity of symptoms scaled 
with IPSS. The IPSS score was categorized according to moderate (IPSS 8-19) or 
sever (IPSS 20-35). It was correlated with the age group. Chi square test was 
applied and result tabulated. The dominant age group (26-30 years) was tested for 
significance. Results showed no significant association (P value 0.68).  
 
Age group Severity score Chi square  P value 
 Moderate Severe  
 
1.51 
 
 
0.68 
20 – 25 5 4 
26 – 30 10 6 
31 – 35 4 6 
36 – 40 6 4 
 
The analysis extended to the total population and plotted in distribution graph. 
Result showed no significant association (p=0.913). 
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r = 0.017, p = 0.913 
 
Gender Vs IPSS: 
Relation of sex and severity of IPSS was tested. The major group, which 
comprised the male population was analysed for association with severity of IPSS. 
Analysis made with Chi square test and result tabulated.  Result showed no 
statistical significance (P value = 0.168).  
Gender  Severity score Chi square  P value 
 Moderate Severe  
1.90 
 
0.168 Male  19 9 
Female  7 10 
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IPSS severity VS early stent removal: 
This was tested in two parts. The variables were IPSS score (either moderate or 
severe) and postoperative day of stent removal. Fisher exact test was applied 
In the moderate IPSS group (IPSS 8-19), when tested for relevance using Fisher 
exact, there was no significant association (Fisher 0.72 Pvalue 0.396) 
In the severe group (IPSS 20-35) after regression analysis showed statistically 
significant association (Pvalue 0.002) 
 
 
 
r = -0.454, p = 0.002 
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IPSS severity and Positive microbial culture: 
IPSS severity was analysed for linkage with positive microbial culture. This was 
done in four settings. First the analysis for done to test IPSS score to that of 
positive microbial of DJ stents. Then the test repeated for positive microbial 
culture of urine. In the third time it was tested for combined positive urine and 
stent culture. Finally the relevance for IPSS group moderate(IPSS 8-19) and 
severe(IPSS 20-35) was analysed. 
The relationship between stent culture and IPSS score was tested. And the result 
was no statistically significant association (P value 0.26). 
The relationship between urine culture and IPSS score was tested. The result was 
not statistically significant (Pvalue 0.27). 
The analysis was done for combined (DJ stent and urine) positive microbial 
culture. IPSS score correlated to severity of combined microbial culture. The result 
was statistically significant with P value 0.001 
IPSS severity and combined positive microbial culture 
Severity   Combined positive culture Chi square P value 
 Yes   No    
10.37 
 
0.001 Moderate   4 21 
Severe  13 7 
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Predictive value of urine culture for positive Stent culture: 
The results of urine culture were correlated with the results of stent culture. The 
result was sought for the sensitivity, specificity, positive predictive value and 
accuracy. The results were tabulated as below. 
 
Predictive value of urine culture: 
Urine culture Stent culture Total 
Positive Negative  
Positive     20 0 17 
Negative 22 3 28 
Total  42 3 45 
 
Sensitivity – 42.1% 
Specificity – 100% 
Positive predictive value – 100% 
Negative predictive value – 21.4% 
% of false negatives – 57.9% 
% of false positives – 0% 
Accuracy – 48.3% 
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Positive microbial culture and early stent removal: 
The significance of positive microbial culture (of DJ stent, urine and combination 
of both) and the predictability of early stent removal was analysed. Timing of 
standard stent removal (3 weeks) was initially tested. Then the patient group was 
divided arbitrarily in to two. One group with stent removal early than 10 days and 
other after 10 days. The results were analysed.   
In the first group, the timing of standard stent removal at 3 weeks was tested  with 
population having positive combined microbial culture, was tested for statistical 
significance, there was no statistical significance (P value 0.247). 
When the test was applied to the arbitrary division of groups based on 10 days as 
early and beyond 10 days as late, the result was found to be statistically 
significant(P value = 0.003). 
 
Combined positive microbial culture Vs early stent removal(standard timing): 
Combined 
positivity   
Stent removal Fisher  P value 
 Early  Late   
1.84 
 
0.247 Yes    16 1 
No   25 3 
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Combined positivite microbial culture and early stent removal (with redefined 
variable): 
Combined 
positivity   
Stent removal Chi square  P value 
 ≤ 10 days >10 days   
8.85 
 
0.003 Yes    13 4 
No   8 20 
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DISCUSSION 
 
Insertion of ureteral stent is a common procedure in modern urology. It is a 
simple and effective method to ensure obstruction free flow of urine from the renal 
pelvis to the bladder. Ureteral stents are commonly used while management of 
stone disease. Ureteroscopy is a common procedure done for ureteric calculus 
causing obstruction. Intracorporeal lithotripsy is done to fragment the stone during 
such procedure. This procedure is usually followed by the insertion of DJ stent. In 
our hospital we experience patients coming for followup with lower urinary tract 
symptoms appearing for the first time after undergoing aforementioned procedure. 
Evaluation of these patients revealed absence of any calculi and most of them can 
be attributed to the DJ stent itself. This is an established and well documented 
observation in various publications. It is also true that the exact cause and 
mechanism for this stent related lower urinary tract symptoms are still unknown. 
Furthermore the correlation of DJ stent culture to that of these stent related 
symptoms are the least evaluated. 
We accrued 45 patients based on our selection criteria. The age limit was 
from 20 – 40 years. This was to eliminate the possible sampling error that occurs in 
old age where LUTS is more common.  Patients are restricted to the age group to 
minimize the possibility of bias that could arise in higher age. Established facts 
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indicate both IPSS and incidence of infection are influenced by age, the most 
skewed at the extremes. Hence we excluded paediatric population and upper age 
limit in this study is 40 years. Though the primary aim is to identify microorganism 
on DJ stent and not to identify urinary tract infection, the restriction of age group 
soundly ensures exclusion of unnecessary bias. It has also been ensured that the 
standard deviation is well within the confines necessary for drawing meaningful 
conclusions. In our study the standard deviation of age is 5.47 years. 
The patient in this study group is a mixed group containing both outpatients 
and inpatients. The patients in the study group are treated initially as follows for 
their symptoms. Following DJ stenting we have standardly prescribed Paracetamol 
tablets and flouroquinolone (mostly Ciprofloxacin) for 3 days. Those patients who 
have persistent symptoms were subjected to urine routine analysis and culture 
sensitivity and treated accordingly. None of the patients in this study group were 
prescribed any α blockers or anticholinergics by us. This we have not prescribed 
primarily because 1) There is still no consistent evidence testifying the 
effectiveness of these agents. 2) The hypothesis proposed for this study suspects 
infection as a cause of LUTS after DJ stenting. Hence it is irrelevant if any drug 
other than antibiotics (based on appropriate supportive evidence in the form of 
culture&sensitivity) should be prescribed. This contradicts the purpose of the 
study. Also if infection is suspected any drug that will hinder bladder emptying 
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(like anti-cholinergics) and prolonging urine stasis is dangerous and unethical 
(based on the proposed hypothesis). However whether some  patients in our study 
group has undergone treatment with various available pharmacological agents 
either by by themselves or upon prescription by someone else (other than those 
involved in the study) could not be completely ruled out. The medication that they 
could have have taken is so diverse that complete documentation and analysis is 
technically not possible. This could be due to concealment of facts. Could be in 
part due to poor documentation of medicines taken by these patients. Even if it is 
narrowed down to one single agent, the diversity of available brands complicates 
the issue further. One thing was very certain.None of them reported increase in 
symptom ‘out of proportion’.  In this minor group of patients, they had  no benefit 
by taking these drugs. This is evident by the very fact that they have come to the 
hospital for the symptoms.  This again strongly supports our hypothesis that the 
real cause is definitely unknown and is not amenable to these pharmaco-
therapeutic agents (either α blockers or anti-cholinergics etc.) and most 
importantly, infection as a potential cause cannot be ruled out. To definitely 
establish an association with these pharmaco-therapeutic agents will require a 
randomized control trial with much larger population. Investigating along these 
lines is beyond the scope of this study. The concern that this population might 
skew the results is unwarranted. This is because; the accrual of the study group is 
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by random selection. Hence there is every chance that this group too is evenly 
distributed in the population proportion of this study. In such case they will not 
statistically influence the results. In fact, the very existence of this minor group of 
patients adds strength to the study by being a representation of the general 
population. This allows us to extrapolate the results with high degree of 
confidence. 
IPSS is a validated questionnaire for LUTS assessment. We utilised IPSS in 
all our patients and their response was documented. IPSS has 7 items and one 
separate for Quality of Life. IPSS has a possible score between 0-35. Among them 
patients with score from 0-7 are taken to have mild symptoms. Patients with score 
9-18 are taken to have moderate symptoms. Score from 20-35 are considered 
severe. In our study the mean IPSS score was 20.25. This value is categorized 
under severe symptoms, indicating that most of the patients are suffering 
significantly due to stent related symptoms. An analysis of this further revealed 
that female patients tend to have more severe stent related symptoms. Symptom 
severity tends to occur in certain group, with moderate symptoms more common in 
26-30 years and severe symptoms more common in 31-35 years. This appears as 
though supporting the previous theory that Lower urinary tract symptoms are sever 
as the age increases. We did a test for statistical significance and found the Pvalue 
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0.913 (not significant). Hence in our study IPSS was not influenced by age 
probably due to our restricted inclusion criteria. 
In our analysis we found that female patients tend to have more severe 
LUTS. We could propose explanation for this based on social stratification, 
psychological health and other factors. But from our analysis the cause for this 
prevalence among female population is unknown. One other possibility is by 
correlating incidence of infection in this population subgroup. It is well known that 
females have higher incidence of UTI than males. This study in fact has the same 
purpose i.e, to identify infective cause for DJ stent related symptoms. If the 
previous statement is true then by mathematical association, we could suspect the 
reason for higher incidence of severe LUTS in female patients who had undergone 
DJ stenting might be due to infective microbial agents. However, in our study the 
test for statistical significance of positive DJ stent culture to that of severity of 
IPSS in this female population was not significant. This could in part due to 
relatively small female sample size in our study group. 
IPSS has in addition the ability to assess Quality of Life of patients with 
stent related LUTS. In our study all our patients reported a minimum of 3 
(indicates mixed feeling to continue living with current LUTS). The majority of the 
patients gave score of 4=unhappy. This could because, the very reason patient has 
come to the hospital is he has bothersome symptoms related to DJ stenting. 
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Statistical testing however revealed lack of its influence on other variables and 
absence of any obvious bias. 
In our study up to 93.33% patient had positive microbial culture on DJ stent. 
It is higher that currently available published reports. Here again the reason could 
be the inclusion criteria. We excluded IPSS of mild symptoms (IPSS 0-7). Infact 
this result indirectly suggests positive correlation of DJ stent culture to that of 
bothersome LUTS. Though a subsequent statistical analysis was required to 
confirm this claim. The most common organism grown in our study was E.coli in 
both DJ stent (48.8%) and urine culture (28.8%). This result is comparable with 
most other published report. This in turn points out indirectly of a positive 
microbial culture to be associated with stent related LUTS. Proving this 
statistically is very difficult and may require much larger sample size. 
Analysing the effect of IPSS on stent removal, we are able to observe 
positive linkage of early stent removal to severe IPSS. In the severe group (IPSS 
20-35) after regression analysis showed statistically significant association (Pvalue 
0.002). This is a favorable observation to prove our ‘research hypothesis’ and 
against the ‘null hypothesis’. This could be substantiated if we could demonstrate 
positive linkage of IPSS to stent culture. Since 90% of our patient had positive 
microbial culture, we could conclude that the linkage is significantly strong. But 
still for statistical purpose we slightly modified it as ‘Combined positive microbial 
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culture’ which include positive DJ stent as well as positive urine culture. This was 
significantly associated with severe IPSS and early stent removal. The test was 
statistically significant (P value 0.001). 
 The predictive value of urine culture to identify coexisted positive microbial 
culture of DJ stent was tested. It is well known that urine culture is not so reliable. 
In our study we found support for this proposition. The urine culture had 
Sensitivity of 42.1% and Specificity of 100% for identifying coexisted DJ stent 
growth. It had a Positive predictive value of 100% and Negative predictive value 
of 21.4%. Hence its accuracy is estimated to be 48.3%. This result is comparable 
with that of other authors. 
Finally we tested for relation between stent culture and early stent removal. 
There was a positive relationship between DJ stent culture and earl stent removal 
(<10 days). This is more so if the patient had concurrent positive urine culture. 
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CONCLUSION 
 
 The prevalence of stent related symptom is significant in incidence. 
  If the stent related symptom occurs, then mostly it is of the severe 
category of IPSS (score20-35).  
 Based on the study it was found that IPSS severity was predominant 
in female population but was not statistically significant.   
 IPSS severity and prevalence of stent culture are not influenced by the 
side of stent or bilaterality.  
 Age of the patients doesnot predict IPSS severity. With reference to 
age the dominant group between 20 to 40 years belonged to the 
subgroup 31-35 years. This prevalence also was not statistically 
significant predictor of increased IPSS or early stent removal.  
 When assessed with Quality of life questionnaire based on IPSS the 
predominant group of patient reported that stent related symptoms a 
score of 4 (mostly dissatisfied).  
 E.coli was the common micro organism grown followed by Klebsiella 
and Pseudomonas. This pattern was the same for both DJ stent culture 
and Urine culture.  
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 The culture characteristics revealed a predominant unimicrobial 
growth pattern.  
 Stent removal was early in patients who had positive culture of both 
DJ stent and urine combined. There is also a strong linkage of higher 
IPSS score to that of positive DJ stent culture and positive urine 
culture. 
  IPSS score is a significant predictor of positive stent culture.  
 IPSS score severity is a definite predictor of early stent removal 
(before 10 days).  
 IPSS severity is a predictor of positive microbial stent culture and 
urine culture. IPSS severity is also conversely predictable by 
combined microbial culture positivity.  
 Multivariate analysis reveals that the severe the IPSS, the higher 
chance of positive microbial culture (either DJ stent, urine or both), 
the earlier the stent removal in these patients.  
 Urine culture has high positive predictive value for presence of DJ 
stent culture. However its accuracy from this study is only 48.3%. 
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